Clin2
NCT06266715Possibly a fitRecruiting

Testing ATP for depression relief

Depression

Part of Mental health clinical trials.

This trial tests if a natural compound called ATP can help improve moderate to severe depression symptoms. If you haven't taken antidepressants recently and have never tried escitalopram, you may be eligible.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Diagnosed with moderate to severe depression
  • Score 20 or higher on a depression rating scale
  • Age 18 to 65
  • No antidepressant use in the past month
  • Never taken escitalopram before
  • No major health issues that would interfere with the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07287878Recruiting
Brain stimulation to improve social reward in depression

This trial tests a new type of brain stimulation called temporal interference stimulation to see if it can improve how people with depression experience social rewards. You may be eligible if you have depression with certain features like increased appetite, weight gain, or feeling very sensitive to rejection, and you are between 16 and 60 years old.

Shanghai, China
NCT07331987Recruiting
Probiotics for mild to moderate anxiety or depression study

This trial tests if probiotics can help reduce symptoms of mild to moderate anxiety or depression. It is for people aged 18–60 who are not currently taking most anxiety or depression medications and who have not used them in the last 2 weeks (except for escitalopram).

Guangzhou, Guangdong
NCT05901571Not yet recruiting
Acupuncture plus escitalopram for major depression

This study tests whether adding acupuncture to escitalopram (an antidepressant) helps people with major depression feel better. It will also compare how the treatment is tolerated and whether depressive symptoms improve.

Shanghai, Shanghai Municipality
NCT06827431Not yet recruiting· Phase 3
Testing ammoxetine for depression

This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.

NCT07032428Not yet recruiting
Testing a new brain stimulation for lack of pleasure in depression

This trial tests a new non-invasive brain stimulation method called kTMP to treat anhedonia (loss of interest or pleasure) in people with major depression. If you have significant anhedonia, this study may help by using a gentle magnetic device to improve your mood.

NCT07480525Recruiting
Escitalopram for first-time depression

This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.

Beijing, Beijing Municipality

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.